Serial Number | 97171522 |
Word Mark | ZOAVE |
Filing Date | Tuesday, December 14, 2021 |
Status | 733 - FOURTH EXTENSION - GRANTED |
Status Date | Monday, August 19, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, July 5, 2022 |
Goods and Services | Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the following systems and organs: autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, integumentary system diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, contraception, drug dependence, fertility disorders, hormone replacement, infectious diseases due to bacteria, viruses, fungi, parasites, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 17, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | TEVA PHARMACEUTICALS USA, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Parsippany, NJ 07054 |
Party Name | TEVA PHARMACEUTICALS USA, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Parsippany, NJ 07054 |
Event Date | Event Description |
Friday, December 17, 2021 | NEW APPLICATION ENTERED |
Friday, December 17, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, May 25, 2022 | ASSIGNED TO EXAMINER |
Wednesday, June 1, 2022 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, June 1, 2022 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, June 1, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, June 1, 2022 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, June 1, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, July 5, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, June 15, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, July 5, 2022 | PUBLISHED FOR OPPOSITION |
Tuesday, August 30, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, February 14, 2023 | SOU TEAS EXTENSION RECEIVED |
Tuesday, February 14, 2023 | SOU EXTENSION 1 FILED |
Tuesday, February 14, 2023 | SOU EXTENSION 1 GRANTED |
Tuesday, February 27, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, February 27, 2024 | SOU EXTENSION 3 FILED |
Tuesday, February 27, 2024 | SOU EXTENSION 3 GRANTED |
Thursday, February 16, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, August 16, 2023 | SOU TEAS EXTENSION RECEIVED |
Wednesday, August 16, 2023 | SOU EXTENSION 2 FILED |
Wednesday, August 16, 2023 | SOU EXTENSION 2 GRANTED |
Friday, August 18, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, August 19, 2024 | SOU TEAS EXTENSION RECEIVED |
Monday, August 19, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, August 19, 2024 | SOU EXTENSION 4 GRANTED |
Monday, August 19, 2024 | SOU EXTENSION 4 FILED |
Wednesday, February 28, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |